Epidermolysis bullosa acquisita (EBA) encompasses a wide spectrum of rare diseases with a common genetic origin transmitted in an autosomal recessive fashion. Mild forms of non-inflammatory EBA are characterized by skin lesions and have gained great relevance in the literature. However, resistant inflammatory EBA with widespread mucosal involvement remains a rare entity given its low prevalence. It commonly represents a great burden for the patient s quality of life with most cases being resistant to different therapeutic modalities.We present a case of resistant inflammatory EBA with esophageal strictures that improved after therapy with intravenous immunoglobulin and rituximab.
|Original language||English (US)|
|Number of pages||3|
|Journal||Oxford Medical Case Reports|
|State||Published - Apr 1 2021|
ASJC Scopus subject areas
- Infectious Diseases